Evolent Health, Inc. (NYSE:EVH) Receives $42.00 Average PT from Brokerages

Shares of Evolent Health, Inc. (NYSE:EVHGet Free Report) have been given an average rating of “Moderate Buy” by the twelve research firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and eleven have issued a buy rating on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $42.00.

Several analysts have recently commented on the stock. JMP Securities reduced their price target on shares of Evolent Health from $38.00 to $34.00 and set a “market outperform” rating on the stock in a research report on Friday, May 10th. JPMorgan Chase & Co. cut their price objective on Evolent Health from $53.00 to $52.00 and set an “overweight” rating for the company in a research report on Friday, March 15th. Citigroup started coverage on shares of Evolent Health in a research report on Monday, April 22nd. They issued a “buy” rating and a $40.00 target price on the stock. Canaccord Genuity Group dropped their price target on shares of Evolent Health from $44.00 to $41.00 and set a “buy” rating for the company in a research report on Friday, May 10th. Finally, Oppenheimer began coverage on shares of Evolent Health in a report on Friday, March 1st. They issued an “outperform” rating and a $45.00 price objective on the stock.

Check Out Our Latest Research Report on Evolent Health

Institutional Trading of Evolent Health

A number of large investors have recently modified their holdings of the stock. NBC Securities Inc. grew its stake in Evolent Health by 16.6% during the 1st quarter. NBC Securities Inc. now owns 2,461 shares of the technology company’s stock worth $81,000 after purchasing an additional 350 shares in the last quarter. New York State Common Retirement Fund increased its stake in shares of Evolent Health by 0.5% during the third quarter. New York State Common Retirement Fund now owns 94,908 shares of the technology company’s stock worth $2,584,000 after buying an additional 506 shares during the period. HMS Capital Management LLC raised its holdings in Evolent Health by 7.8% in the first quarter. HMS Capital Management LLC now owns 7,419 shares of the technology company’s stock valued at $243,000 after acquiring an additional 538 shares in the last quarter. Ascent Group LLC lifted its stake in Evolent Health by 2.8% in the first quarter. Ascent Group LLC now owns 20,330 shares of the technology company’s stock worth $667,000 after acquiring an additional 550 shares during the last quarter. Finally, American International Group Inc. grew its holdings in Evolent Health by 1.2% during the 1st quarter. American International Group Inc. now owns 55,402 shares of the technology company’s stock worth $1,817,000 after acquiring an additional 640 shares in the last quarter.

Evolent Health Stock Down 3.3 %

Shares of NYSE EVH opened at $22.43 on Friday. The stock has a market cap of $2.61 billion, a PE ratio of -17.94 and a beta of 1.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.57. Evolent Health has a 12-month low of $20.54 and a 12-month high of $35.00. The company has a 50-day moving average of $26.09 and a 200 day moving average of $29.53.

Evolent Health (NYSE:EVHGet Free Report) last announced its quarterly earnings data on Thursday, May 9th. The technology company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.04. Evolent Health had a negative net margin of 5.07% and a positive return on equity of 6.90%. The firm had revenue of $639.65 million during the quarter, compared to analyst estimates of $601.60 million. As a group, sell-side analysts predict that Evolent Health will post 0.9 EPS for the current fiscal year.

About Evolent Health

(Get Free Report

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.

Recommended Stories

Analyst Recommendations for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.